Ildstad Suzanne

Director at Talaris Therapeutics, Inc.

Sold, on record
$2.7M
Dollars the filings state
Form 4 sales
13
Latest Jun 14, 2023
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Talaris Therapeutics, Inc.Unusual
    Apr 20, 2023 2023

    Sold 68,743 shares at $2.28 ($156k)

    Ildstad Suzanne, Director

    10b5-1 planSold 2.4% of holdings ($6.6M position)2.8M shares left10.1x usual sizeFiling

  2. 2 Form 144 notice Talaris Therapeutics, Inc.Notice
    Apr 21, 2023 +1 day

    Filed to sell 10,051 shares ($24k)

    Ildstad Suzanne, Officer

    10b5-1 plan1.2x usual sizeFiling

  3. 3 Form 4 sale Talaris Therapeutics, Inc.Routine
    Apr 21, 2023 same day

    Sold 15,004 shares at $2.35 ($35k)

    Ildstad Suzanne, Director

    10b5-1 planSold 0.5% of holdings ($6.7M position)2.8M shares left1.7x usual sizeFollows a Form 144Filing

  4. 4 Form 144 notice Talaris Therapeutics, Inc.Notice
    Jun 1, 2023 +41 days

    Filed to sell 250,000 shares ($663k)

    Ildstad Suzanne, Director

    10b5-1 plan24x usual sizeFiling

  5. 5 Form 4 sale Talaris Therapeutics, Inc.Unusual
    Jun 2, 2023 +1 day

    Sold 31,531 shares at $2.53 ($80k)

    Ildstad Suzanne, Director

    10b5-1 planSold 1.1% of holdings ($7.1M position)2.8M shares left3x usual sizeFollows a Form 144Filing

  6. 6 Form 4 sale Talaris Therapeutics, Inc.Routine
    Jun 6, 2023 +4 days

    Sold 33,390 shares at $2.53 ($84k)

    Ildstad Suzanne, Director

    10b5-1 planSold 1.2% of holdings ($7.1M position)2.8M shares left2.6x usual sizeFollows a Form 144Filing

  7. 7 Form 4 sale Talaris Therapeutics, Inc.Unusual
    Jun 9, 2023 +3 days

    Sold 141,062 shares at $2.43 ($343k)

    Ildstad Suzanne, Director

    10b5-1 planSold 3.6% of holdings ($9.6M position)3.8M shares left9.4x usual sizeFollows a Form 144Filing

  8. 8 Form 4 sale Talaris Therapeutics, Inc.Routine
    Jun 14, 2023 +5 days

    Sold 44,020 shares at $2.55 ($112k)

    Ildstad Suzanne, Director

    10b5-1 planSold 1.2% of holdings ($9.7M position)3.8M shares left1.9x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Ildstad Suzanne
Source
Jun 14, 2023Jun 14, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale44,020$112k1.2%RoutineSEC
Jun 9, 2023Jun 9, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale141,062$343k3.6%UnusualSEC
Jun 6, 2023Jun 7, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale33,390$84k1.2%RoutineSEC
Jun 2, 2023Jun 5, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale31,531$80k1.1%UnusualSEC
Jun 1, 2023Jun 1, 2023Talaris Therapeutics, Inc.DirectorForm 144 notice250,000$663kNoticeSEC
Apr 21, 2023Apr 25, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale15,004$35k0.5%RoutineSEC
Apr 21, 2023Apr 21, 2023Talaris Therapeutics, Inc.OfficerForm 144 notice10,051$24kNoticeSEC
Apr 20, 2023Apr 21, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale68,743$156k2.4%UnusualSEC
Apr 18, 2023Apr 19, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale148,982$319k4.9%UnusualSEC
Mar 17, 2023Mar 20, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale10,436$21k0.3%No planSEC
Mar 3, 2023Mar 7, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale6,806$14k0.2%Plan not statedSEC
Mar 1, 2023Mar 2, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale29$590.0%Plan not statedSEC
Feb 21, 2023Feb 23, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale3,500$7k0.1%Plan not statedSEC
Feb 17, 2023Feb 21, 2023Talaris Therapeutics, Inc.DirectorForm 4 sale6,551$13k0.2%Plan not statedSEC
Aug 22, 2022Aug 23, 2022Talaris Therapeutics, Inc.Chief Scientific OfficerForm 4 sale525,000$1.5M14.6%Plan not statedSEC